A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL (NCT07172893)
A Non-Randomized Open Label Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of DermaBind TL, a Placental Membrane Allograft Intended for Use in the Management of Non-Healing Ulcers
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
Who can join: Review the eligibility criteria below.
Location: Midland Florida Clinical Research Center — DeLand, Florida
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- Midland Florida Clinical Research Center — DeLand, Florida
- Pharmakon Medical Research — Palm Beach Gardens, Florida
- Vital Medical Research — Sweetwater, Florida
- EMbassy Research Network — Bloomfield Township, Michigan
- US Foot and Ankle Specialists-Cary Satellite Site — Cary, North Carolina
- US Foot and Ankle Specialists — Raleigh, North Carolina
- US Foot and Ankle Specialists — Blue Ash, Ohio
- Lower Extremity Institute for Research and Therapy — Boardman, Ohio
- Perfizien Clinical Research, LLC. — Houston, Texas
- Foot and Ankle Specialists of the Mid-Atlantic — Salem, Virginia
📞 Contact the Study Coordinator
Phone: (801) 556-9799
Email: dschmid@healthtechwc.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetic Foot Ulcer (DFU)
- Real-World Effectiveness of Amniotic Membrane Allografts Versus Standard Wound Care in DFU, VLU, and PU — Colorado Springs, Colorado
- Remote Temperature and Visual Monitoring To Help Manage Diabetic Foot Ulcers — North Port, Florida
- HEAL-4: Real-World Effectiveness of 4 Amniotic Allografts Adjunctive to Standard Care in DFU, VLU, and PU — Novi, Michigan
- Evaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound Healing — Chicago, Illinois
- Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers — Hollywood, Florida
- CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations — Oxnard, California
Explore by condition: All Diabetic Foot Ulcer (DFU) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.